Pla2G6 Protein (Ipla2 Vi) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Calcium-independent phospholipase A2 (iPLA2-VI), encoded by the PLA2G6 gene, is a member of the phospholipase A2 family that hydrolyzes the sn-2 position of phospholipids. It is located on chromosome 22q13.1.
iPLA2-VI functions as:
The study of Pla2G6 Protein (Ipla2 Vi) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Paisan-Ruiz C, et al. PLA2G6 mutations in Parkinson's disease with iron accumulation. Brain. 2010;133(Pt 10):3052-3053. PMID:20847376
[2] Malcher C, et al. iPLA2-VI and the pathogenesis of Parkinson's disease. Mov Disord. 2018;33(2):196-199. PMID:29330548
[3] Beck G, et al. Lipid remodeling in Parkinson's disease and neurodegeneration. Neuropharmacology. 2019;144:319-326. PMID:30645890
[4] Wu Y, et al. iPLA2 deficiency leads to mitochondrial dysfunction and dopaminergic neuron loss. J Neurosci. 2012;32(1):239-247. PMID:22219279
[5] Kinghorn KJ, et al. PLA2G6-associated neurodegeneration: clinical features and disease mechanisms. Mol Neurobiol. 2016;53(10):6653-6662. PMID:26843113
[6]Shioda S, et al. Calcium-independent phospholipase A2 in neuronal survival and death. Cell Calcium. 2020;87:102188. PMID:32408247